Assessing experts’ perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State

Author:

Kruger Daniel J.,Kirk Hilary M.,Leonard Kenneth E.,Lynch Joshua J.,Nielsen Nancy,Collins R. Lorraine,Ditre Joseph W.,Fletcher-Blake Debbian,Green Susan A.,Hogue Aaron,Hunter Julia K.,Marraffa John M.,Clemency Brian M.

Abstract

Abstract Background Drug overdose is a leading cause of death and opioid-related deaths increased by more than 300% from 2010 to 2020 in New York State. Experts holding a range of senior leadership positions from across New York State were asked to identify the greatest challenges in substance misuse prevention, harm reduction, and treatment continuum of care. Expert input was used to shape funding priorities. Method Individual semi-structured interviews of sixteen experts were conducted in April and May 2023. Experts included academics, medical directors, leaders of substance misuse service agencies, administrators of a state agency, a county mental health commissioner, the president of a pharmacy chain, and a senior vice president of an addiction-related national non-profit. Zoom interviews were conducted individually by an experienced qualitative interviewer and were recorded, transcribed, and coded for content. An initial report, with the results of the interviews organized by thematic content, was reviewed by the research team and emailed to the expert interviewees for feedback. Results The research team identified five major themes: 1. Siloed and fragmented care delivery systems; 2. Need for a skilled workforce; 3. Attitudes towards addiction (stigma); 4. Limitations in treatment access; and 5. Social and drug related environmental factors. Most experts identified challenges in each major theme; over three-quarters identified issues related to siloed and fragmented systems and the need for a skilled workforce. Each expert mentioned more than one theme, three experts mentioned all five themes and six experts mentioned four themes. Conclusions Research, educational, and programmatic agendas should focus on identified topics as a means of improving the lives of patients at risk for or suffering from substance use-related disorders. The results of this project informed funding of pilot interventions designed to address the identified care challenges.

Funder

New York State Office of Addiction Services and Supports

Publisher

Springer Science and Business Media LLC

Reference40 articles.

1. New York State Department of Health. Priority Area: Mental Health/Substance Abuse-Substance Abuse. https://www.health.ny.gov/prevention/prevention_agenda/mental_health_and_substance_abuseuse/substance_abuse.htm#:~:text=The%20Burden%20of%20Substance%20Abuse&text=Statewide%2C%20over%201.9%20million%20New,a%20figure%20totaling%20over%20750%2C000. Accessed 30 March 2023.

2. New York State Department of Health. Behavioral Risk Factor Surveillance Survey Summary Report. 2020. https://www.health.ny.gov/statistics/brfss/

3. New York State Department of Health. New York State Opioid Data State Dashboard. https://apps.health.ny.gov/public/tabvis/PHIG_Public/opioid/reports/#state. Accessed 13 June 2024.

4. New York State Department of Health. New York State Behavioral Risk Factor Surveillance System Brief: Binge and Heavy Drinking. 2024. https://www.health.ny.gov/statistics/brfss/reports/docs/2024-08_brfss_binge_heavy_drinking.pdf. Accessed 13 June 2024.

5. Caton L, Yuan M, Louie D, et al. The prospects for sustaining evidence-based responses to the US opioid epidemic: state leadership perspectives. Subst Use Treat PR. 2020;15(1):84. https://doi.org/10.1186/s13011-020-00326-x.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3